HCV Protease Inhibitors

DBCAT003771Therapeutic category

A DrugBank category of 2 drugs. 2 of them are approved.

What you can answer from here — as of October 27, 2017

2DrugsEach linked to its full drug card
Listed above
5Drug targetsEvery drug–target pair in the class, with bond type
Sign in
12Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
2Routes of administrationHow the drugs in this class are given
Sign in

Which targets do HCV Protease Inhibitors share, and which companies have late-stage candidates in this class?

Create a free account or log in to explore the full data card.

Create Account